| CK1827452 |
|
| (CAS 873697-71-3) |
 |
| Description： |
Omecamtiv mecarbil (CK-1827452) is a selective sarcomere-directed cardiac myosin activator with an EC50 of 0.6 μM.
Omecamtiv mecarbil, a novel cardiac muscle myosin activator, is currently the subject of a Phase II clinical trials program. This program was designed to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetic profile of both intravenous and oral formulations of omecamtiv mecarbil for the potential treatment of heart failure across the continuum of care, in both hospital and outpatient settings. Omecamtiv mecarbil (CK-1827452; CK1827452 ) is useful for treatment of heart failure.
|
| Product No. |
KT00278 |
| Product Name |
CK1827452 |
| Synonyms |
Omecamtiv mecarbil |
| Formal Name |
|
| CAS Number |
873697-71-3 |
| Molecular Formula |
C20H24FN5O3 |
| Formula Weight |
401.43 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
BTS
ML-7 hydrochloride
TTP 22
TH-302
URB597
URB 754
UK 383367
VU 0364439
VX 770
|
|
